Search
Festuca pratensis pollen
go.drugbank.com/drugs/DB10370ApprovedFestuca pratensis pollen is the pollen of the Festuca pratensis plant. Festuca pratensis pollen is mainly used in allergenic testing.
Products: Standardized Grass Pollen - Meadow Fescue (100 Bau/ml), Standardized Grass Pollen - Meadow Fescue (1000 Bau/ml)Linezolid
go.drugbank.com/drugs/DB00601ApprovedInvestigationalLinezolid was initially approved in 2000 and was the first member of the oxazolidinone antibiotic class. … [L32965] Linezolid exerts its antibacterial activity by inhibiting the initiation of bacterial protein synthesis - more specifically, it binds to the 23S ribosomal RNA of the 50S subunit[A11227,A199050
Synonyms: N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamideProducts: ZYVOX 600MG/300ML INFUSION BAGS, ZIZOLID 100 MG / 5 ML ORAL SÜSPANSİYON HAZIRLAMAK İÇİN KURU TOZ, 150 MLDiltiazem
go.drugbank.com/drugs/DB00343ApprovedInvestigational[T28] Being a potent vasodilator, diltiazem is used clinically as an antihypertensive, anti-arrhythmic, and as an anti-anginal agent [L6289] for the management of cardiovascular conditions such as hypertension … Apart from its main FDA-approved indications, diltiazem has also been used for numerous off-label indications, such as anal fissures (in topical formulations), migraine prophylaxis, pulmonary hypertension
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InhibitorsSynonyms: (+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester, (2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-oneRiboflavin
go.drugbank.com/drugs/DB00140ApprovedInvestigationalNutraceuticalVet approvedIt occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide.
Mixtures: NEUVITAN 50 MG/ 5 ML KAPLI TABLET, 50 ADET, NEUVITAN 50 MG/ 5 ML KAPLI TABLET, 30 ADETSynonyms: 1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol, 7,8-Dimethyl-10-ribitylisoalloxazinePhleum pratense pollen
go.drugbank.com/drugs/DB10394ApprovedInvestigationalPhleum pratense pollen allergenic extract is used in allergenic testing.
Mixtures: Oralair 100 IR, ORALAIR 100 IR + 300 IR SublingualtablettenProducts: Standardized Grass Pollen - Timothy (100 Bau/ml), Standardized Grass Pollen - Timothy (1000 Bau/ml)Mirabegron
go.drugbank.com/drugs/DB08893ApprovedInvestigationalMirabegron has a comparatively favorable adverse effect profile as compared to other available treatment options, and its complementary mechanism to the antimuscarinics that came before it allows for its … [L32853] An extended-release granule formulation was subsequently granted approval in March 2021 for the treatment of pediatric patients with neurogenic detrusor overactivity.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 InhibitorsProducts: BETMIGA 50 MG UZATILMIŞ SALIMLI FILM TABLET ,100 TABLET, BETMIGA 50 MG UZATILMIŞ SALIMLI FILM TABLET , 10 TABLETZonisamide
go.drugbank.com/drugs/DB00909ApprovedInvestigationalZonisamide is a sulfonamide anticonvulsant used as an adjunctive therapy in adults with partial-onset seizures. … In 1989, it was approved for commercial use in Japan. The US and Europe approved it in 2000 and 2005, respectively.[A1379,A1383]
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesProducts: ZONISAHEXAL 50 MG HKP, Zonibon 50 mg-HartkapselnFerric derisomaltose
go.drugbank.com/drugs/DB15617ApprovedInvestigationalFerric derisomaltose was developed by Pharmacosmos Therapeutics ad was granted FDA approval in January 2020. … Iron deficiency results when iron intake, iron stores, and loss of iron from the body do not adequately support production of erythrocytes, also known as red blood cells.
Products: Diafer 50 mg/ml Injektionslösung, Monofer 100 mg/ml Injektions- oder InfusionslösungIbandronate
go.drugbank.com/drugs/DB00710ApprovedInvestigational[L13805,L13808] Ibandronate was first described in the literature in 1993 as a treatment for bone loss in dogs.[A203138] Ibandronate was granted FDA approval on 16 May 2003.[L13805]
Mixtures: IBAMIN D3 150 MG/2800 IU FİLM KAPLI TABLET, 3 ADET, İBAMIN D3 150 MG/2800 IU GRANÜL İÇEREN SAŞE ,3 SAŞEProducts: IBACUR 50 MG ŞASE, 56 ADET, IBACUR 50 MG ŞASE, 28 ADETMethimazole
go.drugbank.com/drugs/DB00763ApprovedInvestigational[L8336,L8339] On a weight basis, methimazole is 10 times more potent than the other major antithyroid thionamide used in North America, [propylthiouracil],[L8339] and is the active metabolite of the … options such as surgery or radioactive iodine therapy are inappropriate.
Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2A6 InhibitorsProducts: PERİZOL 10 MG FİLM KAPLI TABLET, 50 ADET, PERİZOL 10 MG FİLM KAPLI TABLET, 100 ADET